FDA Clearance Tracker · P230014
Lumicell Direct Visualization System (DVS)
Last checked: Nov 19, 2026Latest source record: Apr 17, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Apr 17, 2024
Approved
Time to decision
369 days
Received Apr 14, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P230014
- Device name
- Lumicell Direct Visualization System (DVS)
- Applicant
- Lumicell, Inc.
- Applicant location
- Newton, MA
- Received
- Apr 14, 2023
- Decided
- Apr 17, 2024
- Decision
- Approved
- Supplements
- 4 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR the Lumicell Direct Visualization System. This device is a fluorescence imaging system intended for use in adults with breast cancer as an adjunct for the intraoperative detection of cancerous tissue within the resection cavity following removal of the primary specimen during lumpectomy surgery. The Lumicell Direct Visualization System is used with optical imaging agent LUMISIGHT (pegulicianine) for injection for fluorescence imaging of the lumpectomy cavity.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code SAW (Fluorescence imaging for breast cancer detection).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
Other decisions for Lumicell, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.